<div id=toc></div>

# Table of Contents

- [q-bio.QM](#q-bio.QM) [Total: 2]
- [cs.LG](#cs.LG) [Total: 1]
- [eess.SP](#eess.SP) [Total: 1]
- [cs.CL](#cs.CL) [Total: 1]
- [cs.DS](#cs.DS) [Total: 1]


<div id='q-bio.QM'></div>

# q-bio.QM [[Back]](#toc)

### [1] [GLOMIA-Pro: A Generalizable Longitudinal Medical Image Analysis Framework for Disease Progression Prediction](https://arxiv.org/abs/2507.12500)
*Shuaitong Zhang,Yuchen Sun,Yong Ao,Xuehuan Zhang,Ruoshui Yang,Jiantao Xu,Zuwu Ai,Haike Zhang,Xiang Yang,Yao Xu,Kunwei Li,Duanduan Chen*

Main category: q-bio.QM

TL;DR: GLOMIA-Pro是一个通用的纵向医学图像分析框架，通过提取进展表示和进展感知融合，解决了现有方法在疾病进展预测中的局限性。


<details>
  <summary>Details</summary>
Motivation: 现有方法在建模时空模式时存在通用性不足、忽视疾病分期的序数特性以及易受表示崩溃影响的问题。

Method: GLOMIA-Pro包含进展表示提取模块（使用分段正交注意力和序数进展约束）和进展感知融合模块（改进的跳跃连接架构）。

Result: 在两个临床应用中表现优于七种现有方法，消融实验验证了各模块的有效性。

Conclusion: GLOMIA-Pro具有鲁棒性和通用性，适用于多种临床场景。

Abstract: Longitudinal medical images are essential for monitoring disease progression
by capturing spatiotemporal changes associated with dynamic biological
processes. While current methods have made progress in modeling spatiotemporal
patterns, they face three key limitations: (1) lack of generalizable framework
applicable to diverse disease progression prediction tasks; (2) frequent
overlook of the ordinal nature inherent in disease staging; (3) susceptibility
to representation collapse due to structural similarities between adjacent time
points, which can obscure subtle but discriminative progression biomarkers. To
address these limitations, we propose a Generalizable LOngitudinal Medical
Image Analysis framework for disease Progression prediction (GLOMIA-Pro).
GLOMIA-Pro consists of two core components: progression representation
extraction and progression-aware fusion. The progression representation
extraction module introduces a piecewise orthogonal attention mechanism and
employs a novel ordinal progression constraint to disentangle finegrained
temporal imaging variations relevant to disease progression. The
progression-aware fusion module incorporates a redesigned skip connection
architecture which integrates the learned progression representation with
current imaging representation, effectively mitigating representation collapse
during cross-temporal fusion. Validated on two distinct clinical applications:
knee osteoarthritis severity prediction and esophageal cancer treatment
response assessment, GLOMIA-Pro consistently outperforms seven state-of-the-art
longitudinal analysis methods. Ablation studies further confirm the
contribution of individual components, demonstrating the robustness and
generalizability of GLOMIA-Pro across diverse clinical scenarios.

</details>


### [2] [Continued domain-specific pre-training of protein language models for pMHC-I binding prediction](https://arxiv.org/abs/2507.13077)
*Sergio E. Mares,Ariel Espinoza Weinberger,Nilah M. Ioannidis*

Main category: q-bio.QM

TL;DR: 论文探讨了通过领域特定的预训练提升蛋白质语言模型在pMHC-I结合亲和力预测中的表现。


<details>
  <summary>Details</summary>
Motivation: 由于HLA等位基因多样性高、数据稀缺且实验测量噪声大，当前方法在预测pMHC-I结合亲和力时表现不佳，尤其是对低代表性等位基因和定量预测。

Method: 从ESM Cambrian模型出发，通过掩码语言建模（MLM）对HLA相关肽段进行预训练，测试两种输入格式（单独肽段序列或与HLA重链序列拼接），并使用高质量定量数据微调预测IC50结合亲和力。

Result: 实验结果表明，领域特定的预训练能有效提升模型性能。

Conclusion: 该方法避免了现有方法的质谱偏差，为pMHC-I结合亲和力预测提供了更准确的解决方案。

Abstract: Predicting peptide--major histocompatibility complex I (pMHC-I) binding
affinity remains challenging due to extreme allelic diversity ($\sim$30,000 HLA
alleles), severe data scarcity for most alleles, and noisy experimental
measurements. Current methods particularly struggle with underrepresented
alleles and quantitative binding prediction. We test whether domain-specific
continued pre-training of protein language models is beneficial for their
application to pMHC-I binding affinity prediction. Starting from ESM Cambrian
(300M parameters), we perform masked-language modeling (MLM)-based continued
pre-training on HLA-associated peptides (epitopes), testing two input formats:
epitope sequences alone versus epitopes concatenated with HLA heavy chain
sequences. We then fine-tune for functional IC$_{50}$ binding affinity
prediction using only high-quality quantitative data, avoiding mass
spectrometry biases that are inherited by existing methods.

</details>


<div id='cs.LG'></div>

# cs.LG [[Back]](#toc)

### [3] [Assay2Mol: large language model-based drug design using BioAssay context](https://arxiv.org/abs/2507.12574)
*Yifan Deng,Spencer S. Ericksen,Anthony Gitter*

Main category: cs.LG

TL;DR: Assay2Mol是一个基于大型语言模型的工作流，利用现有生化筛选数据生成候选药物分子，优于其他机器学习方法。


<details>
  <summary>Details</summary>
Motivation: 科学数据库中的非结构化文本（如生物机制描述和实验协议）未被充分利用，Assay2Mol旨在挖掘这些信息以加速药物发现。

Method: Assay2Mol通过检索类似目标的现有筛选记录，并利用上下文学习生成候选分子。

Result: Assay2Mol在生成候选配体分子方面优于其他方法，同时提高了分子的可合成性。

Conclusion: Assay2Mol为早期药物发现提供了一种高效的工具，能够充分利用现有数据资源。

Abstract: Scientific databases aggregate vast amounts of quantitative data alongside
descriptive text. In biochemistry, molecule screening assays evaluate the
functional responses of candidate molecules against disease targets.
Unstructured text that describes the biological mechanisms through which these
targets operate, experimental screening protocols, and other attributes of
assays offer rich information for new drug discovery campaigns but has been
untapped because of that unstructured format. We present Assay2Mol, a large
language model-based workflow that can capitalize on the vast existing
biochemical screening assays for early-stage drug discovery. Assay2Mol
retrieves existing assay records involving targets similar to the new target
and generates candidate molecules using in-context learning with the retrieved
assay screening data. Assay2Mol outperforms recent machine learning approaches
that generate candidate ligand molecules for target protein structures, while
also promoting more synthesizable molecule generation.

</details>


<div id='eess.SP'></div>

# eess.SP [[Back]](#toc)

### [4] [Disentangling coincident cell events using deep transfer learning and compressive sensing](https://arxiv.org/abs/2507.13176)
*Moritz Leuthner,Rafael Vorländer,Oliver Hayden*

Main category: eess.SP

TL;DR: 提出了一种结合全卷积神经网络（FCN）和压缩感知（CS）的混合框架，用于解决单细胞分析中信号重叠问题，显著提高了事件恢复率和分类准确性。


<details>
  <summary>Details</summary>
Motivation: 单细胞分析在诊断和细胞治疗中至关重要，但信号重叠会严重影响数据准确性。

Method: 使用FCN估计重叠事件数量，结合CS模块重构单个信号，并通过磁流式细胞术验证。

Result: 比传统算法多恢复21%的事件，分类准确性超过97%。

Conclusion: 该框架为下一代非光学单细胞传感平台奠定了基础，扩展了细胞术在精准医学中的应用。

Abstract: Accurate single-cell analysis is critical for diagnostics, immunomonitoring,
and cell therapy, but coincident events - where multiple cells overlap in a
sensing zone - can severely compromise signal fidelity. We present a hybrid
framework combining a fully convolutional neural network (FCN) with compressive
sensing (CS) to disentangle such overlapping events in one-dimensional sensor
data. The FCN, trained on bead-derived datasets, accurately estimates
coincident event counts and generalizes to immunomagnetically labeled CD4+ and
CD14+ cells in whole blood without retraining. Using this count, the CS module
reconstructs individual signal components with high fidelity, enabling precise
recovery of single-cell features, including velocity, amplitude, and
hydrodynamic diameter. Benchmarking against conventional state-machine
algorithms shows superior performance - recovering up to 21% more events and
improving classification accuracy beyond 97%. Explinability via class
activation maps and parameterized Gaussian template fitting ensures
transparency and clinical interpretability. Demonstrated with magnetic flow
cytometry (MFC), the framework is compatible with other waveform-generating
modalities, including impedance cytometry, nanopore, and resistive pulse
sensing. This work lays the foundation for next-generation non-optical
single-cell sensing platforms that are automated, generalizable, and capable of
resolving overlapping events, broadening the utility of cytometry in
translational medicine and precision diagnostics, e.g. cell-interaction
studies.

</details>


<div id='cs.CL'></div>

# cs.CL [[Back]](#toc)

### [5] [Improving Drug Identification in Overdose Death Surveillance using Large Language Models](https://arxiv.org/abs/2507.12679)
*Arthur J. Funnell,Panayiotis Petousis,Fabrice Harel-Canada,Ruby Romero,Alex A. T. Bui,Adam Koncsol,Hritika Chaturvedi,Chelsea Shover,David Goodman-Meza*

Main category: cs.CL

TL;DR: NLP模型（如BioClinicalBERT）能高效分类药物过量死亡报告，优于传统方法和通用模型。


<details>
  <summary>Details</summary>
Motivation: 药物过量死亡数据常因人工编码延迟和信息丢失，需自动化解决方案。

Method: 使用多种NLP方法（包括BERT、BioClinicalBERT等）对35,433份死亡记录进行训练和测试，并在外部数据集验证。

Result: BioClinicalBERT表现最佳（内部测试F1≥0.998，外部验证F1=0.966），优于其他模型。

Conclusion: NLP模型（尤其是临床变体）可显著提升药物过量监测效率，支持实时趋势检测。

Abstract: The rising rate of drug-related deaths in the United States, largely driven
by fentanyl, requires timely and accurate surveillance. However, critical
overdose data are often buried in free-text coroner reports, leading to delays
and information loss when coded into ICD (International Classification of
Disease)-10 classifications. Natural language processing (NLP) models may
automate and enhance overdose surveillance, but prior applications have been
limited. A dataset of 35,433 death records from multiple U.S. jurisdictions in
2020 was used for model training and internal testing. External validation was
conducted using a novel separate dataset of 3,335 records from 2023-2024.
Multiple NLP approaches were evaluated for classifying specific drug
involvement from unstructured death certificate text. These included
traditional single- and multi-label classifiers, as well as fine-tuned
encoder-only language models such as Bidirectional Encoder Representations from
Transformers (BERT) and BioClinicalBERT, and contemporary decoder-only large
language models such as Qwen 3 and Llama 3. Model performance was assessed
using macro-averaged F1 scores, and 95% confidence intervals were calculated to
quantify uncertainty. Fine-tuned BioClinicalBERT models achieved near-perfect
performance, with macro F1 scores >=0.998 on the internal test set. External
validation confirmed robustness (macro F1=0.966), outperforming conventional
machine learning, general-domain BERT models, and various decoder-only large
language models. NLP models, particularly fine-tuned clinical variants like
BioClinicalBERT, offer a highly accurate and scalable solution for overdose
death classification from free-text reports. These methods can significantly
accelerate surveillance workflows, overcoming the limitations of manual ICD-10
coding and supporting near real-time detection of emerging substance use
trends.

</details>


<div id='cs.DS'></div>

# cs.DS [[Back]](#toc)

### [6] [Computing and Bounding Equilibrium Concentrations in Athermic Chemical Systems](https://arxiv.org/abs/2507.12699)
*Hamidreza Akef,Minki Hhan,David Soloveichik*

Main category: cs.DS

TL;DR: 本文提出了一种计算分子复合物平衡浓度的迭代算法，专注于聚合物-单体层面的无热相互作用设定，用于DNA纳米技术中优化目标聚合物浓度并最小化非目标聚合物浓度。


<details>
  <summary>Details</summary>
Motivation: 分子复合物平衡浓度的计算通常在分析上难以处理，需要数值方法。现有方法在处理DNA纳米技术中强结合域基础的配置时缺乏有效的理论框架，特别是在区分目标和非目标聚合物浓度方面存在挑战。

Method: 开发了一种迭代算法，用于在无热设定下（所有相互作用保持焓值不变）分配聚合物浓度以满足详细平衡。该方法专注于聚合物-单体层面，其中不可分割的分子（单体）结合形成复合物（聚合物），并与热力学结合网络（TBN）模型的饱和配置保持一致。

Result: 算法能够有效地将目标聚合物浓度设置为高值，将非目标聚合物浓度设置为低值。即使不直接执行，该算法也能提供非目标聚合物浓度上界的有效洞察，将TBN模型等离散配置的组合论证与实值浓度联系起来。在DNA逻辑和信号传播中减少泄漏的应用中验证了方法的有效性。

Conclusion: 该研究为通过熵力区分配置时的平衡浓度设计和验证提供了新的框架。该方法在DNA纳米技术的强结合域基础制度中具有重要应用价值，为分子复合物系统的设计和优化提供了理论支持。

Abstract: Computing equilibrium concentrations of molecular complexes is generally
analytically intractable and requires numerical approaches. In this work we
focus on the polymer-monomer level, where indivisible molecules (monomers)
combine to form complexes (polymers). Rather than employing free-energy
parameters for each polymer, we focus on the athermic setting where all
interactions preserve enthalpy. This setting aligns with the strongly bonded
(domain-based) regime in DNA nanotechnology when strands can bind in different
ways, but always with maximum overall bonding -- and is consistent with the
saturated configurations in the Thermodynamic Binding Networks (TBNs) model.
Within this context, we develop an iterative algorithm for assigning polymer
concentrations to satisfy detailed-balance, where on-target (desired) polymers
are in high concentrations and off-target (undesired) polymers are in low. Even
if not directly executed, our algorithm provides effective insights into upper
bounds on concentration of off-target polymers, connecting combinatorial
arguments about discrete configurations such as those in the TBN model to
real-valued concentrations. We conclude with an application of our method to
decreasing leak in DNA logic and signal propagation. Our results offer a new
framework for design and verification of equilibrium concentrations when
configurations are distinguished by entropic forces.

</details>
